Ultima MT-1 — Research Summary
Ultima MT-1 10mg is a synthetic melanocortin analogue compound manufactured by Ultima Pharmaceuticals for laboratory research applications. MT-1 (Melanotan I) represents a cyclic heptapeptide derivative that serves as a research tool for investigating melanocortin receptor systems and peptide hormone pathways in controlled laboratory environments. Researchers at Stroid UK Shop utilise this compound to examine melanocortin biology, receptor binding affinity studies, and comparative analysis against natural alpha-melanocyte stimulating hormone (α-MSH). The compound maintains structural similarity to endogenous melanocortin peptides while offering enhanced stability characteristics for extended research protocols.
Laboratory Applications
Scientific investigations with MT-1 focus primarily on melanocortin receptor pharmacology and peptide structure-activity relationship studies. Researchers examine binding affinities across MC1-MC5 receptor subtypes, investigating selectivity profiles and downstream signalling cascades in cell culture systems. The compound serves as a valuable tool for comparative studies alongside other melanocortin analogues available in our research compound collection. Laboratory protocols typically investigate cyclic adenosine monophosphate (cAMP) elevation, tyrosinase activity modulation, and melanogenesis pathway activation in appropriate cell lines. Researchers also examine peptide stability under various pH conditions and enzymatic environments. Studies complement broader research programmes involving selective androgen receptor modulators and peptide hormones to understand multi-pathway interactions in metabolic research.
Specification Details
| Parameter | Value |
|---|---|
| Active Compound | Melanotan I |
| Concentration | 10mg per vial |
| Manufacturer | Ultima Pharmaceuticals |
| Form | Lyophilised powder |
| Purity | Verify with supplier |
| CAS Number | Verify with supplier |
| Storage | -20°C, protect from light |
| Reconstitution | Bacteriostatic water |
Research Compliance
Ultima MT-1 10mg is manufactured exclusively for in-vitro research applications and laboratory investigation purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate laboratory protocols, safety procedures, and institutional oversight when handling this research compound. All studies should comply with relevant institutional guidelines and regulatory frameworks governing peptide research materials.
